← Back to all trials
Recruiting
NCT06409832
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Conditions: Migraine, Migraine With Aura, Migraine Without Aura
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 100
Sponsor: University of Florence
Location: SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi Florence Florence
Summary
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of migraine without aura or migraine with aura, according to the 3rd edition of the International Classification of Headache Disorder (ICHD-III);
* At least 4 monthly migraine days;
* Good compliance to study procedures;
* Availability of headache diary at least of the preceding months before enrollment.
Exclusion Criteria:
* Subjects with contraindications for use of gepants;
* Diagnosis of chronic migraine
* Concomitant diagnosis of medical diseases and/or comorbidities that, in the Investigator's opinion might interfere with study assessments;
* medical comorbidities that could interfere with study results;
* Pregnancy and breastfeeding.
* Changes in preventive treatments in the month before the first administration of rimegepant
Source: ClinicalTrials.gov (NCT06409832). StuddyBuddy aggregates publicly available trial information.
